SI1999259T1 - Usmerjeno vključevanje amino kislin v molekule - Google Patents

Usmerjeno vključevanje amino kislin v molekule

Info

Publication number
SI1999259T1
SI1999259T1 SI200731519T SI200731519T SI1999259T1 SI 1999259 T1 SI1999259 T1 SI 1999259T1 SI 200731519 T SI200731519 T SI 200731519T SI 200731519 T SI200731519 T SI 200731519T SI 1999259 T1 SI1999259 T1 SI 1999259T1
Authority
SI
Slovenia
Prior art keywords
molecules
site
amino acids
specific incorporation
incorporation
Prior art date
Application number
SI200731519T
Other languages
English (en)
Inventor
Pin Wang
Inchan Kwon
Soojin Son
Yi Tang
David A. Tirrell
Original Assignee
California Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Institute Of Technology filed Critical California Institute Of Technology
Publication of SI1999259T1 publication Critical patent/SI1999259T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200731519T 2006-03-03 2007-03-05 Usmerjeno vključevanje amino kislin v molekule SI1999259T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77937606P 2006-03-03 2006-03-03
US77937506P 2006-03-03 2006-03-03
PCT/US2007/005581 WO2007103307A2 (en) 2006-03-03 2007-03-05 Site-specific incorporation of amino acids into molecules
EP07752295.1A EP1999259B1 (en) 2006-03-03 2007-03-05 Site-specific incorporation of amino acids into molecules

Publications (1)

Publication Number Publication Date
SI1999259T1 true SI1999259T1 (sl) 2014-11-28

Family

ID=38462077

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731519T SI1999259T1 (sl) 2006-03-03 2007-03-05 Usmerjeno vključevanje amino kislin v molekule

Country Status (11)

Country Link
US (2) US8518666B2 (sl)
EP (1) EP1999259B1 (sl)
JP (2) JP5808882B2 (sl)
AU (2) AU2007224019A1 (sl)
CA (1) CA2644474A1 (sl)
DK (1) DK1999259T3 (sl)
ES (1) ES2504521T3 (sl)
PL (1) PL1999259T3 (sl)
PT (1) PT1999259E (sl)
SI (1) SI1999259T1 (sl)
WO (1) WO2007103307A2 (sl)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287639A1 (en) * 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US7632492B2 (en) * 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
CA2707840A1 (en) * 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US20090148887A1 (en) * 2007-11-02 2009-06-11 The Scripps Research Institute Genetically encoded boronate amino acid
EP2379578A4 (en) * 2009-01-12 2012-05-02 Sutro Biopharma Inc DOUBLE-LOADING SYSTEM FOR THE SELECTIVE INTRODUCTION OF NON-NITIVE AMINO ACIDS IN PROTEINS DUE TO AN IN VITRO-SYNTHESIS PROCESS
WO2010099477A2 (en) 2009-02-27 2010-09-02 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
SG181527A1 (en) * 2009-12-11 2012-07-30 Univ Case Western Reserve Insulin analogues with chlorinated amino acids
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CA2797259C (en) 2010-04-27 2020-09-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
JP6294074B2 (ja) 2010-04-27 2018-03-14 エータイアー ファーマ， インコーポレイテッド イソロイシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
EP2563911B1 (en) 2010-04-28 2021-07-21 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
WO2011139907A2 (en) 2010-04-29 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
WO2011139854A2 (en) 2010-04-29 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
WO2011139988A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
WO2011140135A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
ES2623805T3 (es) 2010-05-03 2017-07-12 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de fenilalanil-alfa-ARNt sintetasas
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CA2798301C (en) 2010-05-04 2020-09-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
EP2566499B1 (en) 2010-05-04 2017-01-25 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
US8945541B2 (en) 2010-05-14 2015-02-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
CN103096914B (zh) 2010-05-17 2015-08-12 Atyr医药公司 与亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
JP6046607B2 (ja) 2010-05-27 2016-12-21 エータイアー ファーマ， インコーポレイテッド グルタミニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
JP5906237B2 (ja) 2010-06-01 2016-04-20 エータイアー ファーマ， インコーポレイテッド リジルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2804416C (en) 2010-07-12 2020-04-28 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
WO2012009289A2 (en) 2010-07-12 2012-01-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
WO2012021249A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
JP6121904B2 (ja) * 2010-09-08 2017-04-26 ハロザイム インコーポレイテッド 条件的活性治療用タンパク質を評価および同定する、または発展させる方法
ES2645019T3 (es) 2010-10-06 2017-12-01 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de triptofanil-ARNt sintetasas
WO2012149160A2 (en) * 2011-04-29 2012-11-01 The Research Foundation Of State University Of New York Viruses modified with unnatural moieties and methods of use thereof
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
HUE046745T2 (hu) * 2011-11-03 2020-03-30 Yeda Res & Dev Transzgenikus növények, amelyek ellenállók nem-fehérje aminosavakra
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
TWI640541B (zh) 2011-12-28 2018-11-11 中外製藥股份有限公司 Peptide compound having an annular portion and pharmaceutical composition thereof
JP6169608B2 (ja) 2011-12-29 2017-07-26 エータイアー ファーマ， インコーポレイテッド アスパルチルｔＲＮＡシンテターゼ−Ｆｃコンジュゲート
WO2013188635A2 (en) * 2012-06-14 2013-12-19 The Trustees Of The University Of Pennsylvania Novel methods of identifying proteins via n-terminal tagging and selective pull-down
DK3460054T3 (da) 2013-03-15 2021-01-18 Atyr Pharma Inc Histidyl-tRNA-syntetase-Fc-konjugater
US20160055293A1 (en) * 2013-03-29 2016-02-25 University Of Washington Through Its Center For Commercialization Systems, Algorithms, and Software for Molecular Inversion Probe (MIP) Design
EP2876165A1 (en) 2013-11-22 2015-05-27 ACIB GmbH Improved method for producing modifed target polypeptides
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
HUE059925T2 (hu) * 2015-03-13 2023-01-28 Chugai Pharmaceutical Co Ltd Módosított aminoacil-tRNS-szintetáz és alkalmazása
GB201600512D0 (en) 2016-01-12 2016-02-24 Univ York Recombinant protein production
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3591048A4 (en) 2017-01-31 2020-12-23 Chugai Seiyaku Kabushiki Kaisha PROCESS FOR SYNTHESIS OF PEPTIDES IN A CELL-FREE TRANSLATION SYSTEM
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
JP6917050B2 (ja) * 2017-03-06 2021-08-11 学校法人早稲田大学 最適特性を有する非天然型タンパク質の製造方法
AU2018256435A1 (en) 2017-04-20 2019-11-07 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
WO2018225851A1 (ja) 2017-06-09 2018-12-13 中外製薬株式会社 Ｎ－置換アミノ酸を含むペプチドの合成方法
CA3070915C (en) * 2017-07-25 2023-08-08 Biocon Limited Peptide mapping method for sequence identification of insulin & insulin analogues
EP3725796A4 (en) 2017-12-15 2021-09-15 Chugai Seiyaku Kabushiki Kaisha METHOD FOR MANUFACTURING PEPTIDE AND METHOD FOR PROCESSING BASES
CN108588040B (zh) * 2018-06-08 2021-06-15 中国医学科学院病原生物学研究所 重组MtMetRS、其晶体及它们在制备抗结核药物中的应用
CA3111576A1 (en) 2018-09-11 2020-03-19 Ambrx, Inc. Interleukin-2 polypeptide conjugates and their uses
JPWO2020111238A1 (ja) 2018-11-30 2021-10-21 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
JP7357642B2 (ja) 2018-12-26 2023-10-06 中外製薬株式会社 コドン拡張のための変異ｔＲＮＡ
CA3133185A1 (en) * 2019-03-13 2020-09-17 St. Jude Children's Research Hospital Vaccine compositions and methods for reducing transmission of streptococcus pneumoniae
WO2021132546A1 (ja) 2019-12-26 2021-07-01 中外製薬株式会社 翻訳用組成物及びペプチドの製造方法
JP2023520049A (ja) 2020-03-31 2023-05-15 プロトマー・テクノロジーズ・インコーポレイテッド 隣接ジオールに対する選択的応答性のためのコンジュゲート
TW202207988A (zh) 2020-05-05 2022-03-01 美商建南德克公司 用於酪胺酸酶媒介的位點特異性蛋白質結合的系統及方法
KR20230028363A (ko) 2020-06-25 2023-02-28 추가이 세이야쿠 가부시키가이샤 개변된 유전 암호표를 갖는 번역계
AU2021382599A1 (en) 2020-11-19 2023-06-22 Protomer Technologies Inc. Aromatic boron-containing compounds and insulin analogs
WO2023069816A2 (en) 2021-09-20 2023-04-27 The Broad Institute, Inc. Compositions and methods for multiplex decoding of quadruplet codons
TW202409070A (zh) 2022-05-18 2024-03-01 美商普羅托莫科技公司 芳族含硼化合物及相關胰島素類似物
WO2023250446A2 (en) * 2022-06-22 2023-12-28 The University Of Chicago ENGINEERED tRNA AND METHODS OF USE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992016640A1 (en) 1991-03-18 1992-10-01 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
DK0974111T3 (da) 1997-04-11 2003-04-22 California Inst Of Techn Apparat og metode til automatiseret design af proteiner
US7449443B2 (en) 2000-03-23 2008-11-11 California Institute Of Technology Method for stabilization of proteins using non-natural amino acids
JP2005502322A (ja) 2001-04-19 2005-01-27 ザ スクリップス リサーチ インスティテュート 非天然アミノ酸のインビボ組込み
US7139665B2 (en) * 2002-02-27 2006-11-21 California Institute Of Technology Computational method for designing enzymes for incorporation of non natural amino acids into proteins
KR20050073559A (ko) 2002-10-16 2005-07-14 더 스크립스 리서치 인스티튜트 당단백질 합성
MXPA06008496A (es) 2004-02-02 2007-01-30 Ambrx Inc Polipeptidos de interferon humano modificados y sus usos.
US20050260711A1 (en) 2004-03-30 2005-11-24 Deepshikha Datta Modulating pH-sensitive binding using non-natural amino acids
US20050287639A1 (en) 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
KR20070039593A (ko) 2004-07-21 2007-04-12 암브룩스, 인코포레이티드 비천연적으로 코딩된 아미노산을 이용한 생합성 폴리펩티드
WO2006034410A2 (en) 2004-09-21 2006-03-30 The Scripps Resarch Institute Adding photoregulated amino acids to the genetic code
US20080064059A1 (en) 2004-10-20 2008-03-13 Scripps Research Institute In Vivo Site-Specific Incorporation of N-Acetyl-Galactosamine Amino Acids in Eubacteria
ATE541934T1 (de) 2004-12-22 2012-02-15 Ambrx Inc Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
US7638491B2 (en) 2004-12-22 2009-12-29 Ambrx, Inc. Therapies using non-natural amino acids and polypeptides
CN101238143A (zh) 2005-06-03 2008-08-06 Ambrx公司 将非天然编码氨基酸并入蛋白质中
AU2005335491B2 (en) 2005-08-18 2010-11-25 Ambrx, Inc. Compositions of tRNA and uses thereof
EP1968635B1 (en) 2005-12-14 2014-09-17 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
KR20080108416A (ko) 2006-01-19 2008-12-15 암브룩스, 인코포레이티드 조절된 면역원성을 갖는 비천연 아미노산 폴리펩티드

Also Published As

Publication number Publication date
US8980581B2 (en) 2015-03-17
PT1999259E (pt) 2014-09-24
EP1999259A2 (en) 2008-12-10
US8518666B2 (en) 2013-08-27
WO2007103307B1 (en) 2008-05-02
JP2013146274A (ja) 2013-08-01
AU2007224019A1 (en) 2007-09-13
US20140045261A1 (en) 2014-02-13
US20080044854A1 (en) 2008-02-21
DK1999259T3 (da) 2014-10-06
WO2007103307A3 (en) 2008-03-13
JP2009528824A (ja) 2009-08-13
JP5808882B2 (ja) 2015-11-10
ES2504521T3 (es) 2014-10-08
AU2014202733A1 (en) 2014-06-12
PL1999259T3 (pl) 2015-01-30
WO2007103307A2 (en) 2007-09-13
EP1999259B1 (en) 2014-06-25
CA2644474A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
PL1999259T3 (pl) Specyficzne miejscowo wprowadzanie aminokwasów do cząsteczek
HRP20181823T1 (hr) Aminokiselinski lipidi i njihove primjene
HK1160459A1 (en) Improved amino lipids and methods for the delivery of nucleic acids
DK1983849T3 (da) Fødevaresammensætning omfattende aminosyrer
GB0625070D0 (en) Characterization of molecules
GB0601513D0 (en) Binding molecules 3
IL197765A0 (en) Methods for purification of polypeptide conjugates
EP1991565A4 (en) SHIGA TOXOID CHIMERIC PROTEINS
EP1809758A4 (en) LOCAL IN VIVO INSTALLATION OF N-ACETYLGALACTOSAMINE AMINO ACIDS IN EU BACTERIA
EP2021352A4 (en) TREATMENT OF PROTEIN MISCONDUCT
GB0620934D0 (en) Protein variants
PL2631241T3 (pl) Sposób generowania białka i jego zastosowanie
IL193422A0 (en) Amide derivative or salt thereof
GB0611116D0 (en) Proteins
GB0626021D0 (en) The stabilisation of proteins
HK1126971A1 (en) Pharmaceutical composition comprising oseltamivir phosphate
GB0601976D0 (en) Proteins
EP2114374A4 (en) PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE
GB0620735D0 (en) Proteins
GB0601511D0 (en) Binding Molecules 2
GB0603865D0 (en) Methods for production of dioic acids
GB0602780D0 (en) Amino Acid Derivatives
GB0602799D0 (en) Non-natural amino acid derivatives
EP2024516A4 (en) Perforin-2 PROTEINS
GB0724832D0 (en) Proteins and nucleic acids